deltatrials
Completed OBSERVATIONAL NCT05620056

A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)

Sponsor: West China Hospital

Updated 3 times since 2022 Last updated: Nov 10, 2022 Started: Jan 1, 2013 Primary completion: Dec 31, 2021 Completion: Nov 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Congenital Malformation and Drug Exposure and is currently completed. West China Hospital leads this study, which shows 3 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

3 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2022 — Jul 2024 [monthly]

    Completed

    First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • West China Hospital
  • Xiamen Health Commission
  • Xiamen Health and Medical Big Data Center
Data source: West China Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations